Sree Rayalaseema Hi-Strength Hypo (BOM:532842) EBIT: ₹1,225 Mil (TTM As of Mar. 2026)


BOM:532842 Sree Rayalaseema Hi-Strength Hypo Ltd BOM:532842
70 GF Score
Price ₹494.40
GF Value ₹468.33
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sree Rayalaseema Hi-Strength Hypo EBIT?

Sree Rayalaseema Hi-Strength Hypo BOM:532842 +2.12% 70 EBIT is ₹1,225 Mil as of Mar. 2026. GuruFocus rates BOM:532842 with a GF Score™ of 70/100 and a GF Value™ of ₹468.33 (Fairly Valued). The stock has 2 warning signs investors should review.

Sree Rayalaseema Hi-Strength Hypo's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹239 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,225 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sree Rayalaseema Hi-Strength Hypo's annualized ROC % for the quarter that ended in Mar. 2026 was 5.93%. Sree Rayalaseema Hi-Strength Hypo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 43.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sree Rayalaseema Hi-Strength Hypo's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 28.19%.


Sree Rayalaseema Hi-Strength Hypo  (BOM:532842) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sree Rayalaseema Hi-Strength Hypo's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=458.972 * ( 1 - 14.36% )/( (0 + 6627.002)/ 1 )
=393.0636208/6627.002
=5.93 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=11153.707 - 138.716 - ( 4387.989 - max(0, 626.292 - 6579.395+4387.989))
=6627.002

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Sree Rayalaseema Hi-Strength Hypo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=954.24/( ( (0 + max(0, 0)) + (872.838 + max(1306.353, 0)) )/ 1 )
=954.24/( ( 0 + 2179.191 )/ 1 )
=954.24/2179.191
=43.79 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(840.415 + 501.29 + 562.992) - (138.716 + 0 + 459.628)
=1306.353

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sree Rayalaseema Hi-Strength Hypo's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=1225.2/4346.577
=28.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sree Rayalaseema Hi-Strength Hypo EBIT Related Terms


Sree Rayalaseema Hi-Strength Hypo EBIT Historical Data

* Premium members only.

The historical data trend for Sree Rayalaseema Hi-Strength Hypo's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sree Rayalaseema Hi-Strength Hypo EBIT Chart

Sree Rayalaseema Hi-Strength Hypo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,389.36 1,931.84 1,085.53 1,211.32 1,225.20

Sree Rayalaseema Hi-Strength Hypo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 279.95 317.48 322.48 346.68 238.56

BOM:532842 vs DOW: EBIT Comparison

For the Chemicals subindustry, Sree Rayalaseema Hi-Strength Hypo's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sree Rayalaseema Hi-Strength Hypo EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Sree Rayalaseema Hi-Strength Hypo's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sree Rayalaseema Hi-Strength Hypo's EV-to-EBIT falls into.


BOM:532842
70GF Score
Sree Rayalaseema Hi-Strength Hypo Ltd BOM:532842
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sree Rayalaseema Hi-Strength Hypo EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,225 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹1,225 Mil mean?
Sree Rayalaseema Hi-Strength Hypo (BOM:532842) has a EBIT of ₹1,225 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sree Rayalaseema Hi-Strength Hypo.
Is Sree Rayalaseema Hi-Strength Hypo's EBIT too high?
Sree Rayalaseema Hi-Strength Hypo's current EBIT is ₹1,225 Mil. Overall, Sree Rayalaseema Hi-Strength Hypo has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sree Rayalaseema Hi-Strength Hypo's EBIT compare to DOW?
Sree Rayalaseema Hi-Strength Hypo's EBIT of ₹1,225 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sree Rayalaseema Hi-Strength Hypo. Sree Rayalaseema Hi-Strength Hypo's current EBIT is ₹1,225 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sree Rayalaseema Hi-Strength Hypo stock overvalued right now?
Based on GuruFocus' analysis, Sree Rayalaseema Hi-Strength Hypo (BOM:532842) is currently considered Fairly Valued. The stock's GF Value™ is ₹468.33, compared to a current price of ₹494.40 — trading 5.6% above its estimated fair value. The current EBIT is ₹1,225 Mil. Sree Rayalaseema Hi-Strength Hypo's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Sree Rayalaseema Hi-Strength Hypo (BOM:532842), the current EBIT is ₹1,225 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sree Rayalaseema Hi-Strength Hypo (BOM:532842) Overvalued in 2026?

Based on GuruFocus' analysis, Sree Rayalaseema Hi-Strength Hypo stock appears to be overvalued. The current stock price of ₹494.40 is trading 5.6% above its estimated GF Value™ of ₹468.33. GuruFocus considers Sree Rayalaseema Hi-Strength Hypo to be Fairly Valued.

Key valuation signals for BOM:532842:

  • EBIT: ₹1,225 Mil
  • GF Value™: ₹468.33 vs. price of ₹494.40 (5.6% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the BOM:532842 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sree Rayalaseema Hi-Strength Hypo Business Description

Other Exchanges SRHHYPOLTD:India
Address 40-304, K.J.S. Complex, Bhagya Nagar, Kurnool, AP, IND, 518004
Sree Rayalaseema Hi-Strength Hypo Ltd is an India-based company engaged in manufacturing inorganic chemicals and generating power through wind and thermal. The company has three reportable segments: Chemical manufacturing and Power Generation, and Trading in Coal, of which Chemical manufacturing segment. The company's products include Sulphuric acid, Chlorosulphonic acid, Chloramine, oleum, Hydrochloric acid, Monochloro acetic acid, Sodium dichloro isocyanurate, Hydrogen gas, Aluminium sulfate, Stable bleaching powder, Sodium hydride, Sodium methoxide powder, Sodium methoxide solution, and Water treatment chemicals.
70GF Score

Get the complete analysis for BOM:532842

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹494.40
Price
₹468.33
GF Value